Logo image of NYC

AMERICAN STRATEGIC INVESTM-A (NYC) Stock Fundamental Analysis

USA - NYSE:NYC - US6494393043 - Common Stock

9.45 USD
-0.52 (-5.22%)
Last: 9/12/2025, 8:04:00 PM
9.88 USD
+0.43 (+4.55%)
After Hours: 9/12/2025, 8:04:00 PM
Fundamental Rating

0

NYC gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. NYC has a bad profitability rating. Also its financial health evaluation is rather negative. NYC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NYC had negative earnings in the past year.
NYC had a negative operating cash flow in the past year.
NYC had negative earnings in each of the past 5 years.
NYC had a negative operating cash flow in each of the past 5 years.
NYC Yearly Net Income VS EBIT VS OCF VS FCFNYC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

NYC has a worse Return On Assets (-19.70%) than 76.19% of its industry peers.
The Return On Equity of NYC (-257.29%) is worse than 79.37% of its industry peers.
Industry RankSector Rank
ROA -19.7%
ROE -257.29%
ROIC N/A
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
NYC Yearly ROA, ROE, ROICNYC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

NYC has a Gross Margin (25.39%) which is in line with its industry peers.
In the last couple of years the Gross Margin of NYC has declined.
NYC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
NYC Yearly Profit, Operating, Gross MarginsNYC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

NYC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NYC has more shares outstanding
Compared to 5 years ago, NYC has more shares outstanding
Compared to 1 year ago, NYC has a worse debt to assets ratio.
NYC Yearly Shares OutstandingNYC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
NYC Yearly Total Debt VS Total AssetsNYC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

NYC has an Altman-Z score of -2.14. This is a bad value and indicates that NYC is not financially healthy and even has some risk of bankruptcy.
NYC has a worse Altman-Z score (-2.14) than 79.37% of its industry peers.
A Debt/Equity ratio of 9.80 is on the high side and indicates that NYC has dependencies on debt financing.
NYC has a Debt to Equity ratio of 9.80. This is amonst the worse of the industry: NYC underperforms 82.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 9.8
Debt/FCF N/A
Altman-Z -2.14
ROIC/WACCN/A
WACC4.66%
NYC Yearly LT Debt VS Equity VS FCFNYC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.44 indicates that NYC may have some problems paying its short term obligations.
With a Current ratio value of 0.44, NYC is not doing good in the industry: 84.13% of the companies in the same industry are doing better.
NYC has a Quick Ratio of 0.44. This is a bad value and indicates that NYC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.44, NYC is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
NYC Yearly Current Assets VS Current LiabilitesNYC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

NYC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.83%, which is quite impressive.
Looking at the last year, NYC shows a very negative growth in Revenue. The Revenue has decreased by -12.40% in the last year.
The Revenue has been decreasing by -2.68% on average over the past years.
EPS 1Y (TTM)52.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-477.11%
Revenue 1Y (TTM)-12.4%
Revenue growth 3Y-4.29%
Revenue growth 5Y-2.68%
Sales Q2Q%-22.41%

3.2 Future

NYC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.45% yearly.
NYC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.40% yearly.
EPS Next Y2.11%
EPS Next 2Y0.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.18%
Revenue Next 2Y2.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NYC Yearly Revenue VS EstimatesNYC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
NYC Yearly EPS VS EstimatesNYC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2023 2024 2025 2026 0 5 -5 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NYC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NYC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NYC Price Earnings VS Forward Price EarningsNYC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

NYC's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 96.68
NYC Per share dataNYC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.45%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NYC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN STRATEGIC INVESTM-A

NYSE:NYC (9/12/2025, 8:04:00 PM)

After market: 9.88 +0.43 (+4.55%)

9.45

-0.52 (-5.22%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners3.55%
Inst Owner Change87.04%
Ins Owners4.5%
Ins Owner Change17.97%
Market Cap24.85M
Analysts45
Price TargetN/A
Short Float %0.58%
Short Ratio1.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.7
EV/EBITDA 96.68
EPS(TTM)-25
EYN/A
EPS(NY)-12.33
Fwd EYN/A
FCF(TTM)-4.39
FCFYN/A
OCF(TTM)-3.91
OCFYN/A
SpS20.86
BVpS13.5
TBVpS13.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.7%
ROE -257.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.39%
FCFM N/A
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 9.8
Debt/FCF N/A
Debt/EBITDA 91.21
Cap/Depr 8.47%
Cap/Sales 2.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z -2.14
F-Score3
WACC4.66%
ROIC/WACCN/A
Cap/Depr(3y)13.9%
Cap/Depr(5y)12.89%
Cap/Sales(3y)5.75%
Cap/Sales(5y)5.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-477.11%
EPS Next Y2.11%
EPS Next 2Y0.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.4%
Revenue growth 3Y-4.29%
Revenue growth 5Y-2.68%
Sales Q2Q%-22.41%
Revenue Next Year3.18%
Revenue Next 2Y2.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.33%
OCF growth 3YN/A
OCF growth 5YN/A